Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within the existing legal framework by rigorously enforcing the provisions of the Clinical Establishments (Registration and Regulation) Act, 2010.

According to an official communication issued by the Union Ministry of Health and Family Welfare, states have been asked to immediately step up implementation of the Act, which mandates registration, minimum standards for infrastructure, staff, and services, and periodic inspections of all clinical establishments — from small nursing homes to large corporate hospitals.

A key focus of the directive is the introduction and enforcement of standardised package rates for common medical procedures and treatments across hospitals. The Centre has emphasised that uniform pricing will protect patients from arbitrary and inflated bills, especially in cases involving health insurance. This step is expected to curb the practice of overcharging and ensure that patients receive fair and predictable treatment costs irrespective of the hospital they choose.

The communication also highlights the urgent need for stronger grievance redressal mechanisms to resolve disputes involving hospitals, insurance companies, and patients. States have been instructed to set up or strengthen dedicated cells or online portals for timely handling of complaints related to overbilling, denial of insurance claims, quality of care, and unethical practices. The Centre has stressed that these mechanisms should be accessible, transparent, and time-bound to build greater trust in the healthcare ecosystem.

The directive comes amid growing concerns over rising out-of-pocket healthcare expenses and frequent conflicts between stakeholders in the insurance sector. By working strictly within the existing provisions of the Clinical Establishments Act, the government aims to achieve better regulation without requiring new legislation.

All states have been asked to submit action-taken reports within the next two months, detailing steps taken to enforce the Act, implement standardised rates, and operationalise robust grievance redressal systems. The Centre has assured full technical and financial support to states for capacity building and digital infrastructure required for effective implementation.

This initiative is being seen as a major step towards making quality healthcare more affordable and accountable for millions of patients across the country.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care